nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaxalone—Haemolytic anaemia—Cladribine—multiple sclerosis	0.0381	0.0381	CcSEcCtD
Metaxalone—Leukopenia—Fingolimod—multiple sclerosis	0.0327	0.0327	CcSEcCtD
Metaxalone—Abdominal discomfort—Cladribine—multiple sclerosis	0.0285	0.0285	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.0234	0.0234	CcSEcCtD
Metaxalone—Abdominal discomfort—Azathioprine—multiple sclerosis	0.0232	0.0232	CcSEcCtD
Metaxalone—Pruritus—Fingolimod—multiple sclerosis	0.0211	0.0211	CcSEcCtD
Metaxalone—Dizziness—Fingolimod—multiple sclerosis	0.0197	0.0197	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.0192	0.0192	CcSEcCtD
Metaxalone—Headache—Fingolimod—multiple sclerosis	0.0187	0.0187	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.0176	0.0176	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.0176	0.0176	CcSEcCtD
Metaxalone—Drowsiness—Mitoxantrone—multiple sclerosis	0.0174	0.0174	CcSEcCtD
Metaxalone—Jaundice—Mitoxantrone—multiple sclerosis	0.017	0.017	CcSEcCtD
Metaxalone—Irritability—Methylprednisolone—multiple sclerosis	0.0162	0.0162	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.016	0.016	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.016	0.016	CcSEcCtD
Metaxalone—Leukopenia—Azathioprine—multiple sclerosis	0.0151	0.0151	CcSEcCtD
Metaxalone—Somnolence—Cladribine—multiple sclerosis	0.015	0.015	CcSEcCtD
Metaxalone—Irritability—Betamethasone—multiple sclerosis	0.0148	0.0148	CcSEcCtD
Metaxalone—Irritability—Dexamethasone—multiple sclerosis	0.0148	0.0148	CcSEcCtD
Metaxalone—Irritability—Prednisone—multiple sclerosis	0.0129	0.0129	CcSEcCtD
Metaxalone—Hypersensitivity—Cladribine—multiple sclerosis	0.0125	0.0125	CcSEcCtD
Metaxalone—Leukopenia—Mitoxantrone—multiple sclerosis	0.0122	0.0122	CcSEcCtD
Metaxalone—Pruritus—Cladribine—multiple sclerosis	0.012	0.012	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.0116	0.0116	CcSEcCtD
Metaxalone—Dizziness—Cladribine—multiple sclerosis	0.0112	0.0112	CcSEcCtD
Metaxalone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.0111	0.0111	CcSEcCtD
Metaxalone—Irritability—Methotrexate—multiple sclerosis	0.0107	0.0107	CcSEcCtD
Metaxalone—Vomiting—Cladribine—multiple sclerosis	0.0107	0.0107	CcSEcCtD
Metaxalone—Rash—Cladribine—multiple sclerosis	0.0107	0.0107	CcSEcCtD
Metaxalone—Dermatitis—Cladribine—multiple sclerosis	0.0106	0.0106	CcSEcCtD
Metaxalone—Headache—Cladribine—multiple sclerosis	0.0106	0.0106	CcSEcCtD
Metaxalone—Hypersensitivity—Azathioprine—multiple sclerosis	0.0101	0.0101	CcSEcCtD
Metaxalone—Nausea—Cladribine—multiple sclerosis	0.01	0.01	CcSEcCtD
Metaxalone—Somnolence—Mitoxantrone—multiple sclerosis	0.00988	0.00988	CcSEcCtD
Metaxalone—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00933	0.00933	CcSEcCtD
Metaxalone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00911	0.00911	CcSEcCtD
Metaxalone—Dizziness—Azathioprine—multiple sclerosis	0.00909	0.00909	CcSEcCtD
Metaxalone—Vomiting—Azathioprine—multiple sclerosis	0.00874	0.00874	CcSEcCtD
Metaxalone—Drowsiness—Methotrexate—multiple sclerosis	0.00868	0.00868	CcSEcCtD
Metaxalone—Rash—Azathioprine—multiple sclerosis	0.00866	0.00866	CcSEcCtD
Metaxalone—Dermatitis—Azathioprine—multiple sclerosis	0.00866	0.00866	CcSEcCtD
Metaxalone—Headache—Azathioprine—multiple sclerosis	0.00861	0.00861	CcSEcCtD
Metaxalone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00838	0.00838	CcSEcCtD
Metaxalone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00836	0.00836	CcSEcCtD
Metaxalone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00818	0.00818	CcSEcCtD
Metaxalone—Nausea—Azathioprine—multiple sclerosis	0.00816	0.00816	CcSEcCtD
Metaxalone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.0076	0.0076	CcSEcCtD
Metaxalone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.0076	0.0076	CcSEcCtD
Metaxalone—Vomiting—Mitoxantrone—multiple sclerosis	0.00706	0.00706	CcSEcCtD
Metaxalone—Rash—Mitoxantrone—multiple sclerosis	0.007	0.007	CcSEcCtD
Metaxalone—Dermatitis—Mitoxantrone—multiple sclerosis	0.007	0.007	CcSEcCtD
Metaxalone—Headache—Mitoxantrone—multiple sclerosis	0.00696	0.00696	CcSEcCtD
Metaxalone—Hypersensitivity—Prednisolone—multiple sclerosis	0.00671	0.00671	CcSEcCtD
Metaxalone—Anaphylactic shock—Prednisone—multiple sclerosis	0.00662	0.00662	CcSEcCtD
Metaxalone—Nausea—Mitoxantrone—multiple sclerosis	0.0066	0.0066	CcSEcCtD
Metaxalone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00617	0.00617	CcSEcCtD
Metaxalone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00616	0.00616	CcSEcCtD
Metaxalone—Leukopenia—Methotrexate—multiple sclerosis	0.00607	0.00607	CcSEcCtD
Metaxalone—Dizziness—Prednisolone—multiple sclerosis	0.00603	0.00603	CcSEcCtD
Metaxalone—Pruritus—Triamcinolone—multiple sclerosis	0.00593	0.00593	CcSEcCtD
Metaxalone—Pruritus—Methylprednisolone—multiple sclerosis	0.00592	0.00592	CcSEcCtD
Metaxalone—Rash—Prednisolone—multiple sclerosis	0.00575	0.00575	CcSEcCtD
Metaxalone—Dermatitis—Prednisolone—multiple sclerosis	0.00574	0.00574	CcSEcCtD
Metaxalone—Headache—Prednisolone—multiple sclerosis	0.00571	0.00571	CcSEcCtD
Metaxalone—Dizziness—Triamcinolone—multiple sclerosis	0.00554	0.00554	CcSEcCtD
Metaxalone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00553	0.00553	CcSEcCtD
Metaxalone—Dizziness—Methylprednisolone—multiple sclerosis	0.00553	0.00553	CcSEcCtD
Metaxalone—Nausea—Prednisolone—multiple sclerosis	0.00541	0.00541	CcSEcCtD
Metaxalone—Pruritus—Betamethasone—multiple sclerosis	0.00538	0.00538	CcSEcCtD
Metaxalone—Pruritus—Dexamethasone—multiple sclerosis	0.00538	0.00538	CcSEcCtD
Metaxalone—Vomiting—Triamcinolone—multiple sclerosis	0.00533	0.00533	CcSEcCtD
Metaxalone—Vomiting—Methylprednisolone—multiple sclerosis	0.00532	0.00532	CcSEcCtD
Metaxalone—Rash—Triamcinolone—multiple sclerosis	0.00528	0.00528	CcSEcCtD
Metaxalone—Dermatitis—Triamcinolone—multiple sclerosis	0.00528	0.00528	CcSEcCtD
Metaxalone—Rash—Methylprednisolone—multiple sclerosis	0.00527	0.00527	CcSEcCtD
Metaxalone—Dermatitis—Methylprednisolone—multiple sclerosis	0.00527	0.00527	CcSEcCtD
Metaxalone—Headache—Triamcinolone—multiple sclerosis	0.00525	0.00525	CcSEcCtD
Metaxalone—Headache—Methylprednisolone—multiple sclerosis	0.00524	0.00524	CcSEcCtD
Metaxalone—Dizziness—Betamethasone—multiple sclerosis	0.00503	0.00503	CcSEcCtD
Metaxalone—Dizziness—Dexamethasone—multiple sclerosis	0.00503	0.00503	CcSEcCtD
Metaxalone—Nausea—Triamcinolone—multiple sclerosis	0.00498	0.00498	CcSEcCtD
Metaxalone—Nausea—Methylprednisolone—multiple sclerosis	0.00497	0.00497	CcSEcCtD
Metaxalone—Somnolence—Methotrexate—multiple sclerosis	0.00492	0.00492	CcSEcCtD
Metaxalone—Hypersensitivity—Prednisone—multiple sclerosis	0.00488	0.00488	CcSEcCtD
Metaxalone—Vomiting—Betamethasone—multiple sclerosis	0.00483	0.00483	CcSEcCtD
Metaxalone—Vomiting—Dexamethasone—multiple sclerosis	0.00483	0.00483	CcSEcCtD
Metaxalone—Rash—Betamethasone—multiple sclerosis	0.00479	0.00479	CcSEcCtD
Metaxalone—Rash—Dexamethasone—multiple sclerosis	0.00479	0.00479	CcSEcCtD
Metaxalone—Dermatitis—Betamethasone—multiple sclerosis	0.00479	0.00479	CcSEcCtD
Metaxalone—Dermatitis—Dexamethasone—multiple sclerosis	0.00479	0.00479	CcSEcCtD
Metaxalone—Headache—Dexamethasone—multiple sclerosis	0.00476	0.00476	CcSEcCtD
Metaxalone—Headache—Betamethasone—multiple sclerosis	0.00476	0.00476	CcSEcCtD
Metaxalone—Pruritus—Prednisone—multiple sclerosis	0.00469	0.00469	CcSEcCtD
Metaxalone—Nausea—Dexamethasone—multiple sclerosis	0.00452	0.00452	CcSEcCtD
Metaxalone—Nausea—Betamethasone—multiple sclerosis	0.00452	0.00452	CcSEcCtD
Metaxalone—Dizziness—Prednisone—multiple sclerosis	0.00438	0.00438	CcSEcCtD
Metaxalone—Vomiting—Prednisone—multiple sclerosis	0.00421	0.00421	CcSEcCtD
Metaxalone—Rash—Prednisone—multiple sclerosis	0.00418	0.00418	CcSEcCtD
Metaxalone—Dermatitis—Prednisone—multiple sclerosis	0.00417	0.00417	CcSEcCtD
Metaxalone—Headache—Prednisone—multiple sclerosis	0.00415	0.00415	CcSEcCtD
Metaxalone—Hypersensitivity—Methotrexate—multiple sclerosis	0.00408	0.00408	CcSEcCtD
Metaxalone—Nausea—Prednisone—multiple sclerosis	0.00393	0.00393	CcSEcCtD
Metaxalone—Pruritus—Methotrexate—multiple sclerosis	0.00392	0.00392	CcSEcCtD
Metaxalone—Dizziness—Methotrexate—multiple sclerosis	0.00366	0.00366	CcSEcCtD
Metaxalone—Vomiting—Methotrexate—multiple sclerosis	0.00352	0.00352	CcSEcCtD
Metaxalone—Rash—Methotrexate—multiple sclerosis	0.00349	0.00349	CcSEcCtD
Metaxalone—Dermatitis—Methotrexate—multiple sclerosis	0.00349	0.00349	CcSEcCtD
Metaxalone—Headache—Methotrexate—multiple sclerosis	0.00347	0.00347	CcSEcCtD
Metaxalone—Nausea—Methotrexate—multiple sclerosis	0.00329	0.00329	CcSEcCtD
